Recruitment Status until April 2024

Status table

The following table provides an update of the UPRIGHT-HTM status since Jan 1, 2024

Centre

City

Jan 1 to April 3, 2024

DEV

PTR

SCR

Rx

FU

SRV

HBP

PRE

001 Mechelen 1 1 1 1 1 1 1 0
003 Lauwe  2 2   2 2 1 3 1
004 Aalst 21 21   12 21 21 21 0
050 GdaƄsk 5 1   12 (+6) 14 (+8) 2 50 49
052 Kraków 81 (+10) 70 (+12) 22 (+7) 48 (+6) 79 (+10) 70 (+11) 100 30
055 Warsaw 17 (+14) 7 (+7)   11 (+10) 15 (+13) 10 (+10) 50 43
250 Ljubljana 10 10 5 (+3) 11 (+2) 11 (+1) 10 28 18
300 Potchefstroom  17 14   14 16 16 50 36
350 Abuja 143 102 80 (+2) 88 (+1) 113 112 145 15
351 Abuja 34 28 22 (+1) 23 34 32
400 Abakaliki 51 (+17) 16 (+5) 3 3 (+1) 41 (+12) 43 (+13) 105 30
401 Katsina 79 (+48) 59 (+37) 1 50 (+26) 60 (+32) 62 (+36)
500 Taipei  23 (+20) 10   47 (+6) 46 (+2) 2 120 109
501 Taipei  2 (+2) 1   1 1  
506 Taipei       1 (+1) 8 (+1)  
505 Tainan  15 (+2) 21 (+2) 1 (+1) 16 (+1) 20 (+2) 12 70 49
600 La Plata 12 (+11)   3 (+3)     11 (+10) 9 9
310 Maputo             30 30
005 Prishtina             50 50
Total   513 (+124) 363 (+63) 138 (+17) 340 (+61) 482 (+81) 405 (+80) 832 469

 

Values in the table represent the number of patients with item available as downloaded from the WIPAM website or number of devices available for BP telemonitoring.  If investigators did not upload the eCRFs in parallel with patient accrual, the numbers tabulated are an underestimate.  Investigators received the number of devices as they requested based on their self-assessed potential for recruiting patients.

Center 305 (Maputo, Mozambique) awaits custom clearance of 30 HTM devices.  Center 600 (La Plata, Argentina) received 9 HTM devices.  One new center is being initiated pending ethical clearance (center 005 in Prishtina, Kosovo).


Items
SCR=screened; Rx=randomised; 
FU= at least 1 follow-up form; SRV=QoL and WHO questionnaire completed; 
PRE=pre-randomisation forms;
DEV=devices available at each centre;
PTR=potential for recruitment;
!!=activation of patient recruitment highly recommended.